Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status.
Marizzoni M, Ferrari C, Babiloni C, Albani D, Barkhof F, Cavaliere L, Didic M, Forloni G, Fusco F, Galluzzi S, Hensch T, Jovicich J, Marra C, Molinuevo JL, Nobili F, Parnetti L, Payoux P, Ranjeva JP, Ribaldi F, Rolandi E, Rossini PM, Salvatore M, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB. Marizzoni M, et al. Among authors: forloni g. Neurobiol Aging. 2020 May;89:55-62. doi: 10.1016/j.neurobiolaging.2019.12.019. Epub 2019 Dec 30. Neurobiol Aging. 2020. PMID: 32029236
MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels.
Fenoglio C, Galimberti D, Lovati C, Guidi I, Gatti A, Fogliarino S, Tiriticco M, Mariani C, Forloni G, Pettenati C, Baron P, Conti G, Bresolin N, Scarpini E. Fenoglio C, et al. Among authors: forloni g. Neurobiol Aging. 2004 Oct;25(9):1169-73. doi: 10.1016/j.neurobiolaging.2003.11.008. Neurobiol Aging. 2004. PMID: 15312962
Influence of the Glu298Asp polymorphism of NOS3 on age at onset and homocysteine levels in AD patients.
Guidi I, Galimberti D, Venturelli E, Lovati C, Del Bo R, Fenoglio C, Gatti A, Dominici R, Galbiati S, Virgilio R, Pomati S, Comi GP, Mariani C, Forloni G, Bresolin N, Scarpini E. Guidi I, et al. Among authors: forloni g. Neurobiol Aging. 2005 Jun;26(6):789-94. doi: 10.1016/j.neurobiolaging.2004.07.003. Neurobiol Aging. 2005. PMID: 15718036 Clinical Trial.
PEN-2 gene mutation in a familial Alzheimer's disease case.
Sala Frigerio C, Piscopo P, Calabrese E, Crestini A, Malvezzi Campeggi L, Civita di Fava R, Fogliarino S, Albani D, Marcon G, Cherchi R, Piras R, Forloni G, Confaloni A. Sala Frigerio C, et al. Among authors: forloni g. J Neurol. 2005 Sep;252(9):1033-6. doi: 10.1007/s00415-005-0799-7. Epub 2005 Mar 16. J Neurol. 2005. PMID: 16170650
Presenilin-1 mutation E318G and familial Alzheimer's disease in the Italian population.
Albani D, Roiter I, Artuso V, Batelli S, Prato F, Pesaresi M, Galimberti D, Scarpini E, Bruni A, Franceschi M, Piras MR, Confaloni A, Forloni G. Albani D, et al. Among authors: forloni g. Neurobiol Aging. 2007 Nov;28(11):1682-8. doi: 10.1016/j.neurobiolaging.2006.07.003. Epub 2006 Sep 6. Neurobiol Aging. 2007. PMID: 16952411
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
Pesaresi M, Batelli S, Prato F, Polito L, Lovati C, Scarpini E, Quadri P, Mariani C, Albani D, Forloni G. Pesaresi M, et al. Among authors: forloni g. Neurobiol Dis. 2007 Mar;25(3):609-13. doi: 10.1016/j.nbd.2006.10.017. Epub 2006 Dec 15. Neurobiol Dis. 2007. PMID: 17174555
381 results